2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
3
Neoplasms
2
Disease
2
Spinal Cord Neoplasms
1
Rectal Neoplasms
1
Pleural Effusion
1
Pleural Diseases
1
Pituitary Neoplasms
1
Parkinson Disease
1
Pancreatitis, Chronic
1
Pancreatic carcinoma, familial
1
Nervous System Diseases
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Hereditary pancreatitis
1
Hematologic Diseases
1
Epilepsy
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Bone Marrow Diseases
1
Interventions
Metformin
8
Surveys and Questionnaires
3
Pioglitazone
3
Nutrition Assessment
3
Methods
3
Exercise
3
Educational Status
3
Tirzepatide
2
Therapeutics
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Resistance Training
2
Interviews as Topic
2
Glucose Tolerance Test
2
Biopsy
2
tocilizumab
1
tislelizumab
1
sofosbuvir-velpatasvir drug combination
1
saxagliptin
1
pembrolizumab
1
otelixizumab
1
nabiximols
1
esmolol
1
epalrestat
1
donafenib
1
dapagliflozin
1
amlodipine, atorvastatin drug combination
1
Verapamil
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diabetes Mellitus
×
Clinical Laboratory Techniques
×
Clear all
NCT04743479
2023-09-01
ESPRIT-AI
Changhai Hospital
Recruiting
5,000 enrolled